Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older

NCT01878812 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Fluarix/Influsplit Tetra® (2013-2014 season)

Sponsor

GlaxoSmithKline